Shareholding disclosure

ADDEX PHARMACEUTICALS LTD

Declared position

16.65%

Threshold

Crossed downwards

Timeline

Published

30.04.2011

Transaction

28.04.2011

Voting rights breakdown

Voting rights acquired1.67%

Voting rights sold16.65%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAB4T00029

Beneficial owner

ADDEX PHARMACEUTICALS LTD

Declared address

ADDEX PHARMACEUTICALS LTD, 1228 PLAN-LES-OUATES

Décision de l'assemblée générale des actionnaires du 28/04/2011 approuvant la création de 409 bons de jouissance supplémentaires, déclenchant le franchissement du seuil de 15% de positions d'aliénation à la hausse.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX PHARMACEUTICALS LTD

Addex Therapeutics Ltd30.04.2011TAB4T00029

Disclosure summary

ADDEX PHARMACEUTICALS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 30.04.2011, at 16.65% of voting rights. Notice category: Single shareholder.

Disclosed position

16.65%

Voting rights sold

Voting rights acquired1.67%

Voting rights sold16.65%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX PHARMACEUTICALS LTD disclosed a holding in Addex Therapeutics Ltd, published on 30.04.2011.

Publication date30.04.2011

Transaction date28.04.2011

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX PHARMACEUTICALS LTD

Declared addressADDEX PHARMACEUTICALS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired1.67%

Voting rights sold16.65%

Below threshold0%

ExchangeXSWX

Notification IDTAB4T00029

Conditions

Décision de l'assemblée générale des actionnaires du 28/04/2011 approuvant la création de 409 bons de jouissance supplémentaires, déclenchant le franchissement du seuil de 15% de positions d'aliénation à la hausse.

Source: SIX Exchange Regulation · Publication date: 30.04.2011

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open